SCHEMBL20508353

SCHEMBL20508353

CC(O)[C@H](C)[C@H](N)[C]=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20508352 1.00
SCHEMBL3321855 0.82
SCHEMBL3321852 0.82
SCHEMBL1570075 0.82
SCHEMBL4093231 0.72
SCHEMBL10723942 0.69
SCHEMBL1064989 0.69
SCHEMBL77706 0.69
SCHEMBL21840885 0.67
SCHEMBL8708711 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240158343-A1 ISOTOPE-ENRICHED 3-AMINO-1-PROPANESULFONIC ACID DERIVATIVES AND USES THEREOF Risen (Suzhou) Pharma Tech Co., Ltd. (CN) 2024-05-16 US disclosed
CN-117534595-A Isotopically enriched 3-amino-1-propanesulfonic acid derivatives and uses thereof 润佳(苏州)医药科技有限公司 2024-02-09 CN disclosed
CN-116785269-A Homotaurine derivatives and uses thereof 润佳(苏州)医药科技有限公司 2023-09-22 CN disclosed
US-20230295079-A1 ISOTOPE-ENRICHED 3-AMINO-1-PROPANESULFONIC ACID DERIVATIVES AND USES THEREOF RISEN SUZHOU PHARMA TECH CO LTD (CN) 2023-09-21 US disclosed
EP-4243802-A1 ISOTOPE-ENRICHED 3-AMINO-1-PROPANESULFONIC ACID DERIVATIVES FOR THE TREATMENT OF CEREBROVASCULAR DISEASE Risen (Suzhou) Pharma Tech Co., Ltd. (CN) 2023-09-20 EP disclosed
CN-116763768-A Isotopically enriched 3-amino-1-propanesulfonic acid derivatives and uses thereof 润佳(苏州)医药科技有限公司 2023-09-19 CN disclosed
CN-116059192-A Use of isotopically enriched 3-amino-1-propanesulfonic acid and derivatives thereof 润佳(苏州)医药科技有限公司 2023-05-05 CN disclosed
CN-112791078-B Use of isotopically enriched 3-amino-1-propanesulfonic acid and derivatives thereof 润佳(苏州)医药科技有限公司 2022-12-06 CN disclosed
CN-114805211-A Isotopically enriched 3-amino-1-propanesulfonic acid derivatives, pharmaceutical compositions and uses thereof 润佳(苏州)医药科技有限公司 2022-07-29 CN disclosed
US-20220202778-A1 ISOTOPE-ENRICHED 3-AMINO-1-PROPANESULFONIC ACID DERIVATIVES FOR THE TREATMENT OF CEREBROVASCULAR DISEASE Risen (Suzhou) Pharma Tech Co., Ltd. (CN) 2022-06-30 US disclosed
WO-2022099412-A1 ISOTOPE-ENRICHED 3-AMINO-1-PROPANESULFONIC ACID DERIVATIVES FOR THE TREATMENT OF CEREBROVASCULAR DISEASE Risen (Suzhou) Pharma Tech Co., Ltd. (CN) 2022-05-19 WO disclosed
CN-108623501-B Isotopically enriched 3-amino-1-propanesulfonic acid derivatives and their use 润佳(苏州)医药科技有限公司 2022-04-19 CN disclosed
US-20210347731-A1 ISOTOPE-ENRICHED 3-AMINO-1-PROPANESULFONIC ACID DERIVATIVES AND USES THEREOF Risen (Suzhou) Pharma Tech Co., Ltd. (CN) 2021-11-11 US disclosed
CN-112791078-A Use of isotopically enriched 3-amino-1-propanesulfonic acid and derivatives thereof 润佳(苏州)医药科技有限公司 2021-05-14 CN disclosed
US-10954188-B2 Isotope-enriched 3-amino-1-propanesulfonic acid derivatives and uses thereof Risen (Suzhou) Pharma Tech Co., Ltd. (CN) 2021-03-23 US disclosed
US-20200223793-A1 ISOTOPE-ENRICHED 3-AMINO-1-PROPANESULFONIC ACID DERIVATIVES AND USES THEREOF RISEN (SUZHOU) PHARMA TECH CO, LTD. (CN) 2020-07-16 US disclosed
EP-3601223-A1 ISOTOPE-ENRICHED 3-AMINO-1-PROPANESULFONIC ACID DERIVATIVES AND USES THEREOF Risen (Suzhou) Pharma Tech Co., Ltd. (CN) 2020-02-05 EP disclosed
US-10472323-B2 Isotope-enriched 3-amino-1-propanesulfonic acid derivatives and uses thereof Risen (Suzhou) Pharma Tech Co., Ltd. (CN) 2019-11-12 US disclosed
WO-2018170590-A1 ISOTOPE-ENRICHED 3-AMINO-1-PROPANESULFONIC ACID DERIVATIVES AND USES THEREOF Risen (Suzhou) Pharma Tech Co., Ltd. (CN) 2018-09-27 WO disclosed
US-20180273471-A1 ISOTOPE-ENRICHED 3-AMINO-1-PROPANESULFONIC ACID DERIVATIVES AND USES THEREOF RISEN (SUZHOU) PHARMA TECH CO. LTD (CN) 2018-09-27 US disclosed